Lv0
0 积分 2024-09-09 加入
Treatment of Psoriasis with II-17 Inhibitors: Comparison of Long-Term Effectiveness and Drug Survival of Secukinumab vs Ixekizumab in Real-World Practice
21小时前
求助中
Long-term Clinical Efficacy, Safety, and Drug Survival of Ixekizumab for Patients with Psoriasis in a Real-life Setting
21小时前
求助中
Psoriasis
1个月前
已完结
Secukinumab demonstrates high efficacy and a favorable safety profile over 52 weeks in Chinese patients with moderate to severe plaque psoriasis
1个月前
已完结
Secukinumab for the treatment of psoriasis, psoriatic arthritis, and axial spondyloarthritis: Physical and pharmacological properties underlie the observed clinical efficacy and safety
1个月前
已完结
Interleukin-17A Drives IL-19 and IL-24 Expression in Skin Stromal Cells Regulating Keratinocyte Proliferation
1个月前
已完结
Efficacy of anti‐IL‐23 and anti‐IL‐17 after adalimumab failure in psoriatic patients
2个月前
已完结
Insights into interplay of immunopathophysiological events and molecular mechanistic cascades in psoriasis and its associated comorbidities
2个月前
已完结
Secukinumab long-term efficacy and safety in psoriasis through to year 5 of treatment: results of a randomized extension of the phase III ERASURE and FIXTURE trials
2个月前
已完结
Psoriasis
5个月前
已完结
皖公网安备34019202002308
